SAGE Publishing provides LaTeX templates for many of its journals. Check this journal’s author guidelines, and we can convert your manuscript into its template.
LaTeX Template Conversion →Journals listed in Web of Science and JCR receive many submissions and desk reject a large share. A section-by-section audit by a PhD reviewer in your area shows what to fix first.
Manuscript Auditing →01Impact factor
Impact factor of Clinical and Applied Thrombosis/Hemostasis (2026)
The impact factor shown here is the 2-year mean citedness: citations received in a year by the papers Clinical and Applied Thrombosis/Hemostasis published in the two previous years, divided by the number of those papers. That is the same formula as the Journal Impact Factor, applied to the open citation data of OpenAlex. The journal is listed in JCR 2024, so it also has an official Journal Impact Factor published by Clarivate, which can differ because it counts citations from Web of Science journals only.
Rank in its subject categories
- Peripheral Vascular Diseasesrank 50 of 109 journals
- Hematologyrank 54 of 104 journals
Ranks here compare journals of the same Web of Science category in our data by 2-year citedness; they are not the official JCR rank.
Quartile of Clinical and Applied Thrombosis/Hemostasis
A journal's quartile (Q1 to Q4) is its position within a subject category: Q1 is the top quarter. The official quartiles are published by Clarivate in Journal Citation Reports (by Journal Impact Factor, in Web of Science categories) and by Scimago as the SJR quartile (in Scopus categories). Clinical and Applied Thrombosis/Hemostasis is listed in JCR 2024, so its JCR quartile is in Journal Citation Reports. It is indexed in Scopus, so Scimago shows its SJR quartile. ScholarsColab does not show a quartile until it can show the official one; the impact factor and rank above are calculated from open data.
Citations and papers per year
Open access (listed in DOAJ); article processing charge listed at about US$2,650.
02Fee waivers
APC waivers and discounts for Clinical and Applied Thrombosis/Hemostasis
Clinical and Applied Thrombosis/Hemostasis follows the waiver policy of its publisher, SAGE: automatic full waiver for Research4Life Group A and a discount for Group B, by the corresponding author's affiliation. Only the corresponding author's affiliation counts. Co-authors from other countries do not change the waiver.
Authors affiliated in 82 countries qualify for a full waiver. See the countries →
Waivers apply to fully open access journals. If Clinical and Applied Thrombosis/Hemostasis is a hybrid journal, you can publish without any fee through the subscription route.
Checking the waiver rules for your country…
Who funds research published in Clinical and Applied Thrombosis/Hemostasis
Funders named most often
A high share of funded papers usually means the journal is a common choice for grant-supported work in its field. If your funder pays article processing charges, or your country qualifies for a waiver, check what applies to your author team with the free APC waiver checker.
Submitting to Clinical and Applied Thrombosis/Hemostasis? See your rejection risk first.
Seven questions our reviewers ask in every audit, plus your abstract and the fit with this journal. Free, no sign-up, about 2 minutes.
03Indexing
Indexing of Clinical and Applied Thrombosis/Hemostasis
- ISSN
- 1076-0296
- eISSN
- 1938-2723
- Publisher
- SAGE Publishing all its journals →
- Subjects
- Hematology, Peripheral Vascular Diseases
From the indexing lists used on ScholarsColab, updated 1 March 2026. Indexing can change: confirm on the Web of Science Master Journal List or the Scopus source list before submitting. Official Journal Impact Factors and JCR quartiles are published by Clarivate; the impact factor and quartile on this page are calculated from OpenAlex open data (see how the impact factor works).
- Web of Science Master Journal List
- SCImago Journal Rank
- ISSN Portal (ISSN 1076-0296)
- DOAJ (Directory of Open Access Journals)
Each link opens the official record for this journal, searched by its ISSN where we have one.
04How to submit
How to submit to Clinical and Applied Thrombosis/Hemostasis
- Read the guide for authors. It sets the article types, word limit, reference style and file format that Clinical and Applied Thrombosis/Hemostasis accepts. You find it on the official website of the journal, usually under "For authors" or "Submit".
- Use the journal's template. SAGE Publishing offers Word and LaTeX templates for many of its journals. If your manuscript is in Word and the journal wants LaTeX, our LaTeX Template Conversion moves it into the template.
- Check the fit. Read the aims and scope and a few recent issues; papers outside the scope are the most common reason for a desk rejection. The Journal Finder shows journals that published the closest work.
- Plan the fee. Clinical and Applied Thrombosis/Hemostasis is fully open access, with an article fee of about US$2,650 after acceptance. See whether your author team qualifies for a waiver with the free APC waiver checker.
- Check your manuscript before you submit. The free Submission Readiness Check asks the seven questions our reviewers ask in every audit and takes about 2 minutes.
05Reviewer comments
Reviewer comments and rejection reasons for Clinical and Applied Thrombosis/Hemostasis
No reviewer or editor comments have been shared for this journal yet. Did you submit here? Help other researchers by sharing the comments you received, anonymously.
Share reviewer comments for this journal →Across the reviewer comments researchers have shared with us, the points raised most often are figures, tables and equations (21%), literature and references (12%) and novelty and contribution (10%). Before you submit to Clinical and Applied Thrombosis/Hemostasis, a Manuscript Audit by a PhD reviewer in your area checks your paper against exactly these points.
Audit my paper before I submit →Not sure yet? Check if your paper is ready for this journal: free, no AI, under 5 secondsPreparing to submit here? Make sure reviewers don't stop at the issues they raise most often. A PhD reviewer in your area can audit your manuscript section by section, and we can convert it into the journal's LaTeX template.
06Same subject
Peripheral Vascular Diseases journals with a similar impact factor*
The journals next to Clinical and Applied Thrombosis/Hemostasis when the 104 journals of Peripheral Vascular Diseases in our data are ranked by impact factor*:
| Rank | Journal | Impact factor* | Indexing | Open access |
|---|---|---|---|---|
| 46 | Journal of the Renin-Angiotensin-Aldosterone System | 1.94 | SCIE | Subscription |
| 47 | CVIR Endovascular | 1.92 | ESCI | Fully open access |
| 48 | Journal of Endovascular Therapy | 1.89 | SCIE | Subscription |
| 49 | Vascular Medicine | 1.88 | SCIE | Subscription |
| 51 | The Journal of Vascular Access | 1.74 | SCIE | Subscription |
| 52 | Atherosclerosis Plus | 1.69 | SCIE | Fully open access |
| 53 | Microcirculation | 1.67 | SCIE | Subscription |
| 54 | Angiology | 1.65 | SCIE | Subscription |
*Impact factor calculated from OpenAlex open data (2-year citedness), not the official Clarivate value.
07Journal Finder
Find the right journal for your paper
Is Clinical and Applied Thrombosis/Hemostasis right for your paper? Compare journals
Paste your title, keywords or abstract. See the journals that published the closest papers, with indexing, impact factor, review time and APC.
No AI or language model is used. Your words are matched against the titles of 156,503 real published journal papers, by our mentors and by other researchers (shown without names); journals are ranked by how many closely matching papers they published. Indexing comes from the SCIE, SSCI, AHCI, ESCI, Scopus and JCR 2024 lists, matched by journal name; the impact factor is calculated from OpenAlex open data, not the official Clarivate value, and no quartile is shown until the official JCR or SJR quartile can be; review time comes from the dates publishers deposit in Crossref (not every publisher deposits them). Always check a journal’s scope and current indexing before submitting.
08Questions
Frequently asked questions
What is the impact factor of Clinical and Applied Thrombosis/Hemostasis?
Based on OpenAlex citation data (October 2026), the 2-year impact factor of Clinical and Applied Thrombosis/Hemostasis is 1.78: papers it published in the two previous years were cited 1.78 times on average in a year. The journal is listed in JCR 2024, so Clarivate also publishes an official Journal Impact Factor, which can differ.
What is the h-index of Clinical and Applied Thrombosis/Hemostasis?
The h-index of Clinical and Applied Thrombosis/Hemostasis is 76 (OpenAlex, October 2026): 76 of its papers have each been cited at least 76 times. Its i10-index is 1,582.
What is the APC of Clinical and Applied Thrombosis/Hemostasis?
OpenAlex lists an article processing charge (APC) of about US$2,650 for Clinical and Applied Thrombosis/Hemostasis, an open access journal (data from October 2026). APCs change and can differ by article type, country or discounts, so confirm the current charge on the journal’s website before submitting.
What is the quartile of Clinical and Applied Thrombosis/Hemostasis?
A journal's quartile (Q1 to Q4) is its position within a subject category: Q1 is the top quarter. The official quartiles are published by Clarivate in Journal Citation Reports (by Journal Impact Factor, in Web of Science categories) and by Scimago as the SJR quartile (in Scopus categories). Clinical and Applied Thrombosis/Hemostasis is listed in JCR 2024, so its JCR quartile is in Journal Citation Reports. It is indexed in Scopus, so Scimago shows its SJR quartile. ScholarsColab does not show a quartile until it can show the official one; the impact factor and rank above are calculated from open data.
Is Clinical and Applied Thrombosis/Hemostasis indexed in Scopus?
Yes. Clinical and Applied Thrombosis/Hemostasis appears in the Scopus list, according to the indexing lists used on ScholarsColab (updated 1 March 2026). Always confirm the current status on the official list before submitting.
Is Clinical and Applied Thrombosis/Hemostasis an SCIE journal?
Yes. Clinical and Applied Thrombosis/Hemostasis is listed in the Science Citation Index Expanded (SCIE), according to the indexing lists used on ScholarsColab (updated 1 March 2026). Always confirm the current status on the official list before submitting.
Is Clinical and Applied Thrombosis/Hemostasis in Journal Citation Reports (JCR)?
Yes. Clinical and Applied Thrombosis/Hemostasis is listed in JCR 2024, so it has a Journal Impact Factor. For the current impact factor and quartile, check Journal Citation Reports.
Does Clinical and Applied Thrombosis/Hemostasis offer an APC waiver?
Clinical and Applied Thrombosis/Hemostasis follows the policy of SAGE: automatic full waiver for Research4Life Group A and a discount for Group B, by the corresponding author's affiliation. Only the corresponding author's affiliation counts. Co-authors from other countries do not change the waiver. Rules verified 27 October 2026; confirm on the publisher's page.
Who funds research published in Clinical and Applied Thrombosis/Hemostasis?
38% of 200 recent research articles in Clinical and Applied Thrombosis/Hemostasis name a funder in Crossref; the funders named most often are National Natural Science Foundation of China, National High Level Hospital Clinical Research Funding, CSL Behring.
Want a PhD expert to choose the journal with you?
Our Journal Selection & Submission service shortlists up to 5 journals that match your manuscript, indexing requirement and target quartile, and handles the submission. If your paper was rejected before, a Manuscript Audit shows what to fix first.
Not sure yet? Check your manuscript for this journal, free · How the process works
Popular journals
- The Lancet
- Nature
- Science
- PLoS ONE
- Scientific Reports
- Journal of the American Chemical Society
- Applied Sciences
- Physical Review
- Sensors
- Frontiers in Microbiology
- Journal of Chemical Physics
- Fuel
- ACS Applied Materials and Interfaces
- Physical Chemistry Chemical Physics
- Materials Letters
- Industrial and Engineering Chemistry Research
- Journal of Physical Chemistry C
- Nature Communications
- European Journal of Pharmacology
- Alzheimer's and Dementia
Browse all journals: indexing, impact factor and reviewer comments →